Literature DB >> 16274491

Current molecular understanding of Axenfeld-Rieger syndrome.

Tord A Hjalt1, Elena V Semina.   

Abstract

Axenfeld-Rieger syndrome (ARS) is a rare autosomal dominant inherited disorder affecting the development of the eyes, teeth and abdomen. The syndrome is characterised by complete penetrance but variable expressivity. The ocular component of the ARS phenotype has acquired most clinical attention and has been dissected into a spectrum of developmental eye disorders, of which open-angle glaucoma represents the main challenge in terms of treatment. Mutations in several chromosomal loci have been implicated in ARS, including PITX2, FOXC1 and PAX6. Full-spectrum ARS is caused primarily by mutations in the PITX2 gene. The homeobox transcription factor PITX2 is produced as at least four different transcriptional and splicing isoforms, with different biological properties. Intriguingly, PITX2 is also involved in left-right polarity determination, although asymmetry defects are not a feature of ARS. In experimental animal models and in cell culture experiments using PITX2, abundant evidence indicates that a narrow window of expression level of this gene is vital for its correct function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16274491     DOI: 10.1017/S1462399405010082

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


  45 in total

1.  Studies on Axenfeld-Rieger syndrome patients and mice reveal Foxc1's role in corneal neovascularization.

Authors:  Mathias François; Ramani Ramchandran
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

Review 2.  Axenfeld-Rieger syndrome and spectrum of PITX2 and FOXC1 mutations.

Authors:  Zeynep Tümer; Daniella Bach-Holm
Journal:  Eur J Hum Genet       Date:  2009-06-10       Impact factor: 4.246

3.  Rieger syndrome with multiple chromosomal breaks and chromosome 4 deletion.

Authors:  Mukesh Tanwar; Rakesh Kumar; Amita Goyal; Manoj Kumar; Tanuj Dada; Gurdeep Singh; Ramanjit Sihota; Rima Dada
Journal:  BMJ Case Rep       Date:  2009-02-16

4.  Conditional disruption of mouse Klf5 results in defective eyelids with malformed meibomian glands, abnormal cornea and loss of conjunctival goblet cells.

Authors:  Doreswamy Kenchegowda; Sudha Swamynathan; Divya Gupta; Huajing Wan; Jeffrey Whitsett; Shivalingappa K Swamynathan
Journal:  Dev Biol       Date:  2011-05-11       Impact factor: 3.582

5.  A Chinese family with Axenfeld-Rieger syndrome: report of the clinical and genetic findings.

Authors:  Da-Peng Sun; Yun-Hai Dai; Xiao-Jing Pan; Tao Shan; Dian-Qiang Wang; Peng Chen
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

6.  Pitx2 regulates myosin heavy chain isoform expression and multi-innervation in extraocular muscle.

Authors:  Yuefang Zhou; Dan Liu; Henry J Kaminski
Journal:  J Physiol       Date:  2011-07-04       Impact factor: 5.182

7.  Axenfeld-Rieger syndrome-associated mutants of the transcription factor FOXC1 abnormally regulate NKX2-5 in model zebrafish embryos.

Authors:  Qinxin Zhang; Dong Liang; Yunyun Yue; Luqingqing He; Nan Li; Dongya Jiang; Ping Hu; Qingshun Zhao
Journal:  J Biol Chem       Date:  2020-07-06       Impact factor: 5.157

Review 8.  Myocardial transcription factors in diastolic dysfunction: clues for model systems and disease.

Authors:  Alexander T Mikhailov; Mario Torrado
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

9.  Conditional deletion of the mouse Klf4 gene results in corneal epithelial fragility, stromal edema, and loss of conjunctival goblet cells.

Authors:  Shivalingappa K Swamynathan; Jonathan P Katz; Klaus H Kaestner; Ruth Ashery-Padan; Mary A Crawford; Joram Piatigorsky
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

10.  Noggin producing, MyoD-positive cells are crucial for eye development.

Authors:  Jacquelyn Gerhart; Jessica Pfautz; Christine Neely; Justin Elder; Kevin DuPrey; A Sue Menko; Karen Knudsen; Mindy George-Weinstein
Journal:  Dev Biol       Date:  2009-09-22       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.